Adding attenuation corrected images in myocardial perfusion imaging reduces the need for a rest study

BMC Medical Imaging

Research Article

Sven Valind¹  Elin Trägårdh¹  Lars Edenbrandt¹ 

[1] Clinical Physiology and Nuclear Medicine Unit, Skåne University Hospital, Lund University, Entrance 44, 205 05, Malmö, Sweden;

关键词: Tc99m MPS;    Ischemic cardiac disease;    Attenuation correction;    Stress-only studies;   

DOI  :  10.1186/1471-2342-13-14

 received in 2012-01-26, accepted in 2013-03-27,  发布年份 2013

来源: Springer

【 摘 要 】

BackgroundThe American Society of Nuclear Cardiology and the Society of Nuclear Medicine conclude that incorporation of attenuation corrected (AC) images in myocardial perfusion scintigraphy (MPS) will improve diagnostic accuracy. The aim was to investigate the value of adding AC stress-only images for the decision whether a rest study is necessary or not.Methods1,261 patients admitted to 99mTc MPS were studied. The stress studies were interpreted by two physicians who judged each study as “no rest study necessary” or “rest study necessary”, by evaluating NC stress-only and NC + AC stress-only images. When there was disagreement between the two physicians, a third physician evaluated the studies. Thus, agreement between 2 out of 3 physicians was evaluated.ResultsThe physicians assessed 214 more NC + AC images than NC images as “no rest study necessary” (17% of the study population). The number of no-rest-study-required was significantly higher for NC + AC studies compared to NC studies (859 vs 645 cases (p < 0.0001). In the final report according to clinical routine, ischemia or infarction was reported in 23 patients, assessed as “no rest study necessary” (22 NC + AC cases; 8 NC cases), (no statistically significant difference). In 11 of these, the final report stated “suspected/possible ischemia or infarction in a small area”.ConclusionsAdding AC stress-only images to NC stress-only images reduce the number of unnecessary rest studies substantially.

【 授权许可】

CC BY   
© Trägårdh et al.; licensee BioMed Central Ltd. 2013